Detection of Bacillus subtilis spores using peptide-functionalized cantilever arrays

Journal of the American Chemical Society
Babita DhayalPhilip S Low

Abstract

We move beyond antibody-antigen binding systems and demonstrate that short peptide ligands can be used to efficiently capture Bacillus subtilis (a simulant of Bacillus anthracis) spores in liquids. On an eight-cantilever array chip, four cantilevers were coated with binding peptide (NHFLPKV-GGGC) and the other four were coated with control peptide (LFNKHVP-GGGC) for reagentless detection of whole B. subtilis spores in liquids. The peptide-ligand-functionalized microcantilever chip was mounted onto a fluid cell filled with a B. subtilis spore suspension for approximately 40 min; a 40 nm net differential deflection was observed. Fifth-mode resonant frequency measurements were also performed before and after dipping microcantilever arrays into a static B. subtilis solution showing a substantial decrease in frequency for binding-peptide-coated microcantilevers as compared to that for control peptide cantilevers. Further confirmation was obtained by subsequent examination of the microcantilever arrays under a dark-field microscope. Applications of this technology will serve as a platform for the detection of pathogenic organisms including biowarfare agents.

References

Aug 1, 1985·Journal of Medical Microbiology·N A LoganR C Berkeley
Mar 31, 2000·Ultramicroscopy·M K BallerH J Guntherodt
Sep 14, 2001·Letters in Applied Microbiology·S I MakinoK Takeshi
Jan 17, 2002·Critical Reviews in Microbiology·R M Atlas
May 1, 2002·JAMA : the Journal of the American Medical Association·Thomas V InglesbyUNKNOWN Working Group on Civilian Biodefense
Jul 27, 2002·Annual Review of Microbiology·Ronald M Atlas
Nov 7, 2003·Applied and Environmental Microbiology·Jordan KnurrCharles L Turnbough
May 29, 2004·Analytical Chemistry·Cagri A SavranScott R Manalis
Aug 4, 2004·Toxicology and Applied Pharmacology·Deepak K Bhalla, David B Warheit
Sep 8, 2004·Advanced Drug Delivery Reviews·Rashid Bashir
May 5, 2005·Applied and Environmental Microbiology·Karin Y GfellerMartin Hegner
Nov 1, 2005·Biosensors & Bioelectronics·Natalia NugaevaMartin Hegner

❮ Previous
Next ❯

Citations

Dec 21, 2006·Journal of the American Chemical Society·W Matthew LeevyBradley D Smith
Aug 3, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Alexandre BongrainPhilippe Bergonzo
Sep 27, 2007·Lab on a Chip·Philip S Waggoner, Harold G Craighead
Mar 12, 2011·The Analyst·Koutilya R BuchapudiThomas Thundat
Jul 20, 2010·Annual Review of Analytical Chemistry·Kyo Seon HwangTae Song Kim
Sep 4, 2007·The Review of Scientific Instruments·R ZhangR Cain
Mar 29, 2014·Sensors·Simin MehrabaniAndrea M Armani
Sep 9, 2015·Chemical Reviews·Sundus Erbas-CakmakAlina L Nussbaumer
Mar 22, 2014·Frontiers in Microbiology·Ekaterina OsmekhinaPeter Neubauer
May 15, 2007·Current Opinion in Chemical Biology·Jennifer A MaynardBenjamin Roy
Nov 30, 2006·Angewandte Chemie·Euan R KayFrancesco Zerbetto
Oct 1, 2010·Critical Reviews in Microbiology·Jacques TheronMichele de Kwaadsteniet
Jul 11, 2009·Organic & Biomolecular Chemistry·Sabrina LusvarghiBruce Alan Armitage
Jan 1, 2015·Microarrays·Amir SyahirHisakazu Mihara
May 29, 2020·International Journal of Biological Macromolecules·Somayyeh Dabbagh SadeghpourHoushang Alizadeh
Apr 30, 2010·Analytical Chemistry·Zhou LongMichael J Sepaniak
Jan 25, 2007·Journal of the American Chemical Society·Ghanashyam AcharyaCagri A Savran
Dec 30, 2006·Analytical Chemistry·Peter J ChapmanMichael J Sepaniak
Jan 31, 2008·Chemical Reviews·Karen M GoedersLawrence A Bottomley
Nov 1, 2006·Langmuir : the ACS Journal of Surfaces and Colloids·Bin SunRobert J Hamers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.